Torrent Pharmaceuticals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TORNTPHARM.BO | AUROPHARMA.BO | SUNPHARMA.NS | GRANULES.BO | TEVA | JUBLPHARMA.BO | |
|---|---|---|---|---|---|---|
| Market cap | 1.60T | 1.04T | 4.39T | 192.80B | 48.81B | 150.00B |
| P/E (TTM) | 74.6 | 30.4 | 40.0 | 35.3 | 97.3 | 42.7 |
| Forward P/E | 52.7 | 23.9 | 29.0 | 26.5 | 13.4 | 18.7 |
| Price/book | 18.9 | 3.0 | 4.9 | 4.8 | 6.1 | 2.1 |
| Dividend yield | 0.79% | 0.33% | 0.90% | 0.26% | — | 0.53% |
| 1-year change | +27.43% | +1.70% | +5.19% | +0.63% | +71.10% | −19.11% |
| Today | −0.25% | +5.13% | +3.14% | −0.01% | −0.14% | +0.79% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All TORNTPHARM.BO news ›Torrent Pharmaceuticals informs about RTA’s corporate office address change
Torrent Pharmaceuticals Limited has notified exchanges about a change in the corporate office address of its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited. The new address will be effective from December 1, 2026. All…
Torrent Pharmaceuticals announces relocation of KFin Technologies' corporate office
Torrent Pharmaceuticals Limited has announced a significant update related to its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited. As per the intimation dated 2nd November 2026, the corporate office of KFin Technologies…
Buy Torrent Pharmaceuticals; target of Rs 5500: Prabhudas Lilladher- Moneycontrol.com
Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 5500 in its research report dated October 25, 2026. Buy Torrent Pharmaceuticals; target of Rs 5500: Prabhudas…
Torrent Pharmaceuticals Q2 Results FY27: Net Profit Falls 9.64% To ₹534 Crore Despite 50.78% Revenue Growth
New Delhi, Oct 23: Torrent Pharmaceuticals on Friday reported a 9.64 per cent decline in consolidated net profit to Rs 534 crore in the September quarter of the current fiscal. The company had posted a consolidated net profit of Rs 591…
Torrent Pharmaceuticals Share Price Gains on Market Action
Torrent Pharmaceuticals Ltd. (TORNTPHARM) rose to Rs 4,641.45 from the previous close of Rs 4,527.55, a move of Rs 113.9 or 2.52%. The stock opened at Rs 4,518.05, reached a high of Rs 4,641.45, recorded a low of Rs 4,510.05. Torrent…
Who is Amal Kelshikar? Why did he resign from the position of Torrent Pharmaceuticals' Executive Director? Explained
Torrent Pharmaceuticals has accepted the resignation of its Executive Director, Amal Kelshikar. His resignation became effective from 16 October, 2026, at the close of business hours. The filing was made under Regulation 30 of SEBI Listing…
Torrent Pharmaceuticals TORNTPHARM Executive Director Resignation
Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director? Kalkine India Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director? Source: Krish Capital Pty Ltd Torrent Pharmaceuticals Limited…
More from 1 other outlet
Torrent Pharmaceuticals TORNTPHARM Analyst Call Oct 2026
Kalkine India Torrent Pharmaceuticals (NSE:TORNTPHARM): What Is the October 2026 Analyst Call About? Source: Krish Capital Pty Ltd Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) filed an exchange notice on 9th October 2026 informing…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.co.in2
- freepressjournal.in1
- livemint.com1
- moneycontrol.com1
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.